Opus Genetics (IRD) Stock Research

Opus Genetics

· IRD

Dashboard

Financials

Ratios

Valuation

Statistics

412.235 M

-2.32%

Over a week ago

What You Missed On Wall Street On Wednesday

+26

Sep 9, 4:28 PM

Opus Genetics price target raised by $3 at Leerink, here's why

Sep 9, 4:10 PM

Opus Genetics price target raised by $10 at Oppenheimer, here's why

Sep 9, 3:37 PM

Opus Genetics price target raised by $3 at Chardan, here's why

Sep 9, 1:35 PM

Midday Fly By: Analog acquires Alif, Independence Realty merges with Centerspace

+28

Sep 9, 12:01 PM

Opus Genetics announces results from low-dose Cohort 1 of BIRD-1 trial

Sep 9, 7:28 AM

Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed

Aug 19, 4:09 PM

Opus Genetics price target lowered by $1 at RBC Capital

Aug 7, 8:24 AM

Opus Genetics files $300M mixed securities shelf

Aug 7, 6:23 AM

Opus Genetics reports Q2 EPS (14c), consensus (16c)

Aug 6, 7:19 AM

Opus Genetics enrolls last patient in OPGx-LCA5 trial

Aug 3, 7:49 AM

Opus Genetics initiated with bullish view at TD Cowen, here's why

Jul 29, 5:33 AM

Opus Genetics sets September timeline for retinal disease trial data

Jul 9, 9:09 AM

Opus Genetics FDA alignment further de-risks path to market, says Chardan

Jul 6, 9:53 AM

Morning Movers: TeraWulf surges following lease agreement with Anthropic

Jul 6, 8:56 AM

Opus Genetics announces FDA alignment on OPGx-LCA5 trial

Jul 6, 7:08 AM

Opus Genetics to join Russell 3000, Russell 2000 and Russell Microcap Indexes

Jun 26, 9:17 AM

Opus Genetics initiated with bullish view at RBC Capital, here's why

Jun 23, 6:45 AM

Opus Genetics assumed with a Buy at Chardan

Jun 17, 8:24 PM

Opus Genetics management to meet with BTIG

Jun 12, 1:35 PM

Opus Genetics registers to sell 2.68M shares of common stock for holders

Jun 5, 4:34 PM

Opus Genetics initiated with bullish view at Guggenheim

Jun 4, 6:12 AM

Opus Genetics management to meet with Citizens

Jun 3, 1:53 PM

Charts

Over a week ago

What You Missed On Wall Street On Wednesday

+26

Sep 9, 4:28 PM

Opus Genetics price target raised by $3 at Leerink, here's why

Sep 9, 4:10 PM

Opus Genetics price target raised by $10 at Oppenheimer, here's why

Sep 9, 3:37 PM

Opus Genetics price target raised by $3 at Chardan, here's why

Sep 9, 1:35 PM

Midday Fly By: Analog acquires Alif, Independence Realty merges with Centerspace

+28

Sep 9, 12:01 PM

Opus Genetics announces results from low-dose Cohort 1 of BIRD-1 trial

Sep 9, 7:28 AM

Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed

Aug 19, 4:09 PM

Opus Genetics price target lowered by $1 at RBC Capital

Aug 7, 8:24 AM

Opus Genetics files $300M mixed securities shelf

Aug 7, 6:23 AM

Opus Genetics reports Q2 EPS (14c), consensus (16c)

Aug 6, 7:19 AM

Opus Genetics enrolls last patient in OPGx-LCA5 trial

Aug 3, 7:49 AM

Opus Genetics initiated with bullish view at TD Cowen, here's why

Jul 29, 5:33 AM

Opus Genetics sets September timeline for retinal disease trial data

Jul 9, 9:09 AM

Opus Genetics FDA alignment further de-risks path to market, says Chardan

Jul 6, 9:53 AM

Morning Movers: TeraWulf surges following lease agreement with Anthropic

Jul 6, 8:56 AM

Opus Genetics announces FDA alignment on OPGx-LCA5 trial

Jul 6, 7:08 AM

Opus Genetics to join Russell 3000, Russell 2000 and Russell Microcap Indexes

Jun 26, 9:17 AM

Opus Genetics initiated with bullish view at RBC Capital, here's why

Jun 23, 6:45 AM

Opus Genetics assumed with a Buy at Chardan

Jun 17, 8:24 PM

Opus Genetics management to meet with BTIG

Jun 12, 1:35 PM

Opus Genetics registers to sell 2.68M shares of common stock for holders

Jun 5, 4:34 PM

Opus Genetics initiated with bullish view at Guggenheim

Jun 4, 6:12 AM

Opus Genetics management to meet with Citizens

Jun 3, 1:53 PM

Company News

Charts

Opus Genetics

· IRD

Dashboard

Financials

Ratios

Valuation

Statistics

Company News

Charts

Opus Genetics

· IRD

Dashboard

Financials

Ratios

Valuation

Statistics